POS0938 MAINTENANCE OF RESPONSE TO BIMEKIZUMAB OVER 3 YEARS OF TREATMENT IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: POST HOC ANALYSES FROM THE BE AGILE STUDY AND ITS OPEN-LABEL EXTENSION
Navarro-Compán, V., Rudwaleit, M., De Peyrecave, N., Fleurinck, C., Oortgiesen, M., Taieb, V., Baraliakos, X.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
POS0247 RESOLUTION OF ENTHESITIS AND PERIPHERAL ARTHRITIS WITH BIMEKIZUMAB IN PATIENTS WITH AXIAL SPODYLOARTHRITIS: WEEK 52 RESULTS FROM THE BE MOBILE 1 AND BE MOBILE 2 PHASE 3 STUDIES
Ramiro, S, Poddubnyy, D, Mease, P J, López-Medina, C, Fleurinck, C, Kim, M, Massow, U, Taieb, V, Kragstrup, T W, Mcgonagle, D
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
AB1000 ACHIEVEMENT OF INCREASINGLY STRINGENT CLINICAL RESPONSE CRITERIA AND LOWER LEVELS OF DISEASE ACTIVITY WAS ASSOCIATED WITH GREATER IMPROVEMENTS IN PHYSICAL FUNCTION AND HRQOL IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS: 52-WEEK RESULTS FROM TWO PHASE 3 STUDIES ON BIMEKIZUMAB
Magrey, M, Deodhar, A, Mease, P J, Navarro-Compán, V, Ramiro, S, Rudwaleit, M, De la Loge, C, Fleurinck, C, Taieb, V, Morup, M, Oortgiesen, M, Kay, J
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
POS1104 BIMEKIZUMAB MAINTAINED STRINGENT CLINICAL RESPONSES THROUGH WEEK 52 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE PHASE 3 STUDIES BE MOBILE 1 AND BE MOBILE 2
Proft, F, Van der Heijde, D, Baraliakos, X, Ermann, J, Fleurinck, C, Massow, U, De Peyrecave, N, Taieb, V, A Van Tubergen, Navarro-Compán, V
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
POS1106 ACHIEVEMENT OF LOW DISEASE ACTIVITY OVER 52 WEEKS IN PATIENTS WITH ACTIVE AXIAL SPONDYLOARTHRITIS ON BIMEKIZUMAB TREATMENT: RESULTS FROM THE PHASE 3 STUDIES BE MOBILE 1 AND BE MOBILE 2
Baraliakos, X, Ramiro, S, Magrey, M, Rudwaleit, M, Haroon, N, Fleurinck, C, Massow, U, De Peyrecave, N, Vaux, T, Marzo-Ortega, H, Navarro-Compán, V
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
POS0246 BIMEKIZUMAB REDUCED MRI INFLAMMATORY LESIONS IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: WEEK 52 RESULTS FROM THE BE MOBILE 1 AND BE MOBILE 2 PHASE 3 STUDIES
Baraliakos, X, Navarro-Compán, V, Poddubnyy, D, Dubreuil, M, Bennett, A, Jans, L, Massow, U, Fleurinck, C, Vaux, T, Ellis, A, De Peyrecave, N, Maksymowych, W P
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
POS1103 BIMEKIZUMAB MAINTAINED IMPROVEMENTS IN EFFICACY ENDPOINTS AND HAD A CONSISTENT SAFETY PROFILE THROUGH 52 WEEKS IN PATIENTS WITH NON-RADIOGRAPHIC AND RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM TWO PARALLEL PHASE 3 STUDIES
Baraliakos, X, Deodhar, A, Van der Heijde, D, Magrey, M, Maksymowych, W P, Tomita, T, H Xu, Oortgiesen, M, Massow, U, Fleurinck, C, Ellis, A, Vaux, T, Smith, J, Marten, A, Gensler, L S
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
AB0938 SAFETY PROFILE OF BIMEKIZUMAB AT WEEK 16 IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: RESULTS FROM FOUR PLACEBO-CONTROLLED PHASE 3 STUDIES
Poddubnyy, D, Gensler, L S, Mease, P J, Orbai, A M, Warren, R B, Ink, B, Massow, U, Assudani, D, Fleurinck, C, Shende, V, Smith, J, Peterson, L, White, K, Landewé, R B M
Published in Annals of the rheumatic diseases (01.06.2023)
Published in Annals of the rheumatic diseases (01.06.2023)
Get full text
Journal Article
PCR68 Association of Clinical Response Criteria and Disease Activity Levels with Physical Function and HRQoL in Patients with Axial Spondyloarthritis: 52-Week Results from Two Phase 3 Randomized, Placebo-Controlled Studies
Magrey, M., Deodhar, A., Mease, P.J., Navarro-Compán, V., Ramiro, S., Fleurinck, C., Taieb, V., Mørup, M., Massow, U., Kay, J.
Published in Value in health (01.06.2023)
Published in Value in health (01.06.2023)
Get full text
Journal Article
POS0919 BIMEKIZUMAB SHOWS SUSTAINED LONG-TERM IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE IN ANKYLOSING SPONDYLITIS: 3-YEAR RESULTS FROM A PHASE 2B STUDY
Baraliakos, X., Dougados, M., Gaffney, K., Sengupta, R., Magrey, M., De Peyrecave, N., Oortgiesen, M., Vaux, T., Fleurinck, C., Deodhar, A.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
POS0226 BIMEKIZUMAB LONG-TERM SAFETY AND EFFICACY IN PATIENTS WITH ANKYLOSING SPONDYLITIS: 3-YEAR RESULTS FROM A PHASE 2B STUDY
Van der Heijde, D., Deodhar, A., Gensler, L. S., Poddubnyy, D., Kivitz, A., Dougados, M., De Peyrecave, N., Oortgiesen, M., Vaux, T., Fleurinck, C., Baraliakos, X.
Published in Annals of the rheumatic diseases (01.06.2021)
Published in Annals of the rheumatic diseases (01.06.2021)
Get full text
Journal Article
POS0939 BIMEKIZUMAB IN PATIENTS WITH ACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 1, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO‑CONTROLLED STUDY
Deodhar, A., Van der Heijde, D., Gensler, L. S., Xu, H., Gaffney, K., Dobashi, H., Maksymowych, W. P., Rudwaleit, M., Magrey, M., Elewaut, D., Oortgiesen, M., Fleurinck, C., Ellis, A., Vaux, T., Smith, J., Baraliakos, X.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
OP0019 BIMEKIZUMAB IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS: 24-WEEK EFFICACY & SAFETY FROM BE MOBILE 2, A PHASE 3, MULTICENTRE, RANDOMISED, PLACEBO-CONTROLLED STUDY
Van der Heijde, D., Baraliakos, X., Dougados, M., Brown, M., Poddubnyy, D., Van den Bosch, F., Haroon, N., Xu, H., Tomita, T., Gensler, L. S., Oortgiesen, M., Fleurinck, C., Vaux, T., Marten, A., Deodhar, A.
Published in Annals of the rheumatic diseases (01.06.2022)
Published in Annals of the rheumatic diseases (01.06.2022)
Get full text
Journal Article
PCR196 Association of Clinical Response Criteria and Disease Activity Levels With Physical Function and HRQoL in Patients With Active Axial Spondyloarthritis: 16-Week Results From Two Phase 3 Randomised, Placebo-Controlled Studies
Magrey, M, Deodhar, A, Mease, PJ, Navarro-Compán, V, Ramiro, S, Rudwaleit, M, de la Loge, C, Fleurinck, C, Taieb, V, Mørup, MF, Oortgiesen, M, Kay, J
Published in Value in health (01.12.2022)
Published in Value in health (01.12.2022)
Get full text
Journal Article
Impact du bimékizumab sur les domaines évalués par le GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) chez les patients atteints de rhumatisme psoriasique (RhPso) : résultats à 52 semaines issus de 4 études de phase III
Gossec, L., Merola, J.F., Mease, P.J., Deodhar, A., Ink, B., Fleurinck, C., Bajracharya, R., Coarse, J., Coates, L.C.
Published in Revue du rhumatisme (Ed. française : 1993) (01.12.2023)
Published in Revue du rhumatisme (Ed. française : 1993) (01.12.2023)
Get full text
Journal Article
Résolution des enthésites et des arthrites périphériques avec le bimékizumab chez les patients atteints de spondyloarthrite axiale : résultats à la semaine 52 des études de phase III BE MOBILE 1 et BE MOBILE 2
Dougados, M., Ramiro, S., Poddubnyy, D., Mease, P.J., López-Medina, C., Fleurinck, C., Kim, M., Massow, U., Taieb, V., Wenzel Kragstrup, T., McGonagle, D.
Published in Revue du rhumatisme (Ed. française : 1993) (01.12.2023)
Published in Revue du rhumatisme (Ed. française : 1993) (01.12.2023)
Get full text
Journal Article
Le bimékizumab réduit les lésions inflammatoires à l’IRM chez les patients atteints de spondyloarthrite axiale : résultats à la semaine 52 des études de phase III BE MOBILE 1 et 2
Dougados, M., Baraliakos, X., Navarro-compán, V., Poddubnyy, D., Dubreuil, M., Bennett, A., Jans, L., Massow, U., Fleurinck, C., Vaux, T., Ellis, A.M., De Peyrecave, N., Maksymowych, W.P.
Published in Revue du rhumatisme (Ed. française : 1993) (01.12.2023)
Published in Revue du rhumatisme (Ed. française : 1993) (01.12.2023)
Get full text
Journal Article
Le bimékizumab permet le maintien des réponses cliniques évaluées par des critères stricts jusqu’à la semaine 52 chez les patients atteints de spondyloarthrite axiale : résultats des études de phase III BE MOBILE 1 et BE MOBILE 2
Dougados, M., Proft, F., Van Der Heijde, D., Baraliakos, X., Ermann, J., Fleurinck, C., Massow, U., De Peyrecave, N., Taieb, V., Van Tubergen, A., Navarro-compán, V.
Published in Revue du rhumatisme (Ed. française : 1993) (01.12.2023)
Published in Revue du rhumatisme (Ed. française : 1993) (01.12.2023)
Get full text
Journal Article
Le bimékizumab améliore la fonction physique et la qualité de vie liée à l’état de santé chez les patients atteints de spondyloarthrite axiale : résultats de deux études de phase III
Breban, M., Dubreuil, M., Gaffney, K., Gensler, L.S., Kay, J., Navarro-Compán, V., De La Loge, C., Ellis, A.M., Fleurinck, C., Oortgiesen, M., Taieb, V., Deodhar, A.
Published in Revue du rhumatisme (Ed. française : 1993) (01.12.2022)
Published in Revue du rhumatisme (Ed. française : 1993) (01.12.2022)
Get full text
Journal Article